Mometasone furoate/olopatadine : List of nationally authorised medicinal products - PSUSA/00010957/202304
Mometasone furoate/olopatadine : List of nationally authorised medicinal products - PSUSA/00010957/202304
Mometasone furoate/olopatadine : List of nationally authorised medicinal products - PSUSA/00010957/202304
human plasma (pooled and treated for virus inactivation) : List of nationally authorised medicinal products - PSUSA/00001635/202302
Plasma master file certificates
Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) Multistakeholder workshop on Patient Registries, European Medicines Agency, Amsterdam, the Netherlands, from 12/02/2024 to 13/02/2024
EMEA-002545-PIP01-19-M01
Opinion/decision on a Paediatric investigation plan (PIP): Atropine (sulfate), decision type: , therapeutic area: , PIP number: P/0416/2022
EMEA-002350-PIP04-21
EMEA-001468-PIP01-13
Opinion/decision on a Paediatric investigation plan (PIP): (E)-4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)oxy]-1-azoniatricyclo[3.3.1.13,7] decane 3,4-dicarboxy-3-hydroxybutanoate hydrate (ABT-126), decision type: , therapeutic area: , PIP number: P/0081/2014
Opinion/decision on a Paediatric investigation plan (PIP): Deucravacitinib, decision type: , therapeutic area: , PIP number: P/0286/2022